Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
Lisa Ricciardi, president and CEO of Cognition Therapeutics was recently a guest on Benzinga's All-Access. Cognition ...
Irish Examiner on MSN2d
Breakthrough drugs herald ‘new era’ in battle against dementia, experts predictMedical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
The third most common form of dementia is often mistaken for Alzheimer's despite different treatment needsCognitive profiles ...
The findings show that the increased ... Study Identifies Potential New Drug for Parkinson's-Related Cognitive Decline, Dementia Nov. 19, 2024 — A recently published study found that a tiny ...
Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.
Vitamin D also helps clear beta amyloid, a protein that plays a role in Alzheimer’s disease, Merrill points out. This is “the ...
A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback